The CDMO offers comprehensive chemistry, environmental, and microbial capabilities at the facilities, in addition to multi-compendial testing and customized analysis.
According to the company, the Edison site is capable of meeting FDA requirements for Antibiotic Analysis both using USP < 81 > and can perform bridging analysis to an alternative method per USP < 1223.1 >.
Additionally, Alcami has added 2,000 cubic feet of stability chamber space across its network, new control systems for all chambers, and a REES environmental monitoring system.
The company is also working to adopt Lean principles at its laboratories, a process which is said will be completed in 2017.
Alcami did not respond to a request for comment.